| Review Article Online Published: 03 Nov 2025 | ||||||||||||
IJMDC. 2025; 9(10): 2508-2518 SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review Shahad Abduljalil Abualhamael, Raghad Tawfiq Alasmi, Ruba Eid Alsubhi, Norah Sultan Alharbi, Sirin Mohammed Aljaghthami, Renad Abdullah Alrdeeni, Noor Alfaraj, Alaa Essa Hakami, Buthaynah Abdullah Alharthi, Razan Ghassan Wali, Asmaa Fayez Ahmed Ekram.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Abualhamael SA, Alasmi RT, Alsubhi RE, Alharbi NS, Aljaghthami SM, Alrdeeni RA, Alfaraj N, Hakami AE, Alharthi BA, Wali RG, Ekram AFA. SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review. IJMDC. 2025; 9(10): 2508-2518. doi:10.24911/IJMDC.51-1756302416 Web Style Abualhamael SA, Alasmi RT, Alsubhi RE, Alharbi NS, Aljaghthami SM, Alrdeeni RA, Alfaraj N, Hakami AE, Alharthi BA, Wali RG, Ekram AFA. SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review. https://www.ijmdc.com/?mno=280067 [Access: December 10, 2025]. doi:10.24911/IJMDC.51-1756302416 AMA (American Medical Association) Style Abualhamael SA, Alasmi RT, Alsubhi RE, Alharbi NS, Aljaghthami SM, Alrdeeni RA, Alfaraj N, Hakami AE, Alharthi BA, Wali RG, Ekram AFA. SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review. IJMDC. 2025; 9(10): 2508-2518. doi:10.24911/IJMDC.51-1756302416 Vancouver/ICMJE Style Abualhamael SA, Alasmi RT, Alsubhi RE, Alharbi NS, Aljaghthami SM, Alrdeeni RA, Alfaraj N, Hakami AE, Alharthi BA, Wali RG, Ekram AFA. SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review. IJMDC. (2025), [cited December 10, 2025]; 9(10): 2508-2518. doi:10.24911/IJMDC.51-1756302416 Harvard Style Abualhamael, S. A., Alasmi, . R. T., Alsubhi, . R. E., Alharbi, . N. S., Aljaghthami, . S. M., Alrdeeni, . R. A., Alfaraj, . N., Hakami, . A. E., Alharthi, . B. A., Wali, . R. G. & Ekram, . A. F. A. (2025) SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review. IJMDC, 9 (10), 2508-2518. doi:10.24911/IJMDC.51-1756302416 Turabian Style Abualhamael, Shahad Abduljalil, Raghad Tawfiq Alasmi, Ruba Eid Alsubhi, Norah Sultan Alharbi, Sirin Mohammed Aljaghthami, Renad Abdullah Alrdeeni, Noor Alfaraj, Alaa Essa Hakami, Buthaynah Abdullah Alharthi, Razan Ghassan Wali, and Asmaa Fayez Ahmed Ekram. 2025. SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review. International Journal of Medicine in Developing Countries, 9 (10), 2508-2518. doi:10.24911/IJMDC.51-1756302416 Chicago Style Abualhamael, Shahad Abduljalil, Raghad Tawfiq Alasmi, Ruba Eid Alsubhi, Norah Sultan Alharbi, Sirin Mohammed Aljaghthami, Renad Abdullah Alrdeeni, Noor Alfaraj, Alaa Essa Hakami, Buthaynah Abdullah Alharthi, Razan Ghassan Wali, and Asmaa Fayez Ahmed Ekram. "SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review." International Journal of Medicine in Developing Countries 9 (2025), 2508-2518. doi:10.24911/IJMDC.51-1756302416 MLA (The Modern Language Association) Style Abualhamael, Shahad Abduljalil, Raghad Tawfiq Alasmi, Ruba Eid Alsubhi, Norah Sultan Alharbi, Sirin Mohammed Aljaghthami, Renad Abdullah Alrdeeni, Noor Alfaraj, Alaa Essa Hakami, Buthaynah Abdullah Alharthi, Razan Ghassan Wali, and Asmaa Fayez Ahmed Ekram. "SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review." International Journal of Medicine in Developing Countries 9.10 (2025), 2508-2518. Print. doi:10.24911/IJMDC.51-1756302416 APA (American Psychological Association) Style Abualhamael, S. A., Alasmi, . R. T., Alsubhi, . R. E., Alharbi, . N. S., Aljaghthami, . S. M., Alrdeeni, . R. A., Alfaraj, . N., Hakami, . A. E., Alharthi, . B. A., Wali, . R. G. & Ekram, . A. F. A. (2025) SGLT2 inhibitors in heart failure and chronic kidney disease: a systematic review. International Journal of Medicine in Developing Countries, 9 (10), 2508-2518. doi:10.24911/IJMDC.51-1756302416 |